References
Schwarz MI, Fontenot AP (2004) Drug-induced diffuse alveolar hemorrhage syndromes and vasculitis. Clin Chest Med 25:133–140
Sakai M, Kubota T, Kuwayama Y et al (2011) Diffuse alveolar hemorrhage associated with lenalidomide. Int J Hematol 93:830–831
Tsuyuguchi K, Wada M (2011) Management of adverse effect with antituberculousis chemotherapy. Kekkaku 86:87–99
Dimopoulos M, Spencer A, Attal M et al (2007) Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma. N Engl J Med 357:2123–2132
Weber DM, Chen C, Niesvizky R et al (2007) Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America. N Engl J Med 357:2133–2142
Thornburg A, Abonour R, Smith P et al (2007) Hypersensitivity pneumonitis-like syndrome associated with the use of lenalidomide. Chest 131:1572–1574
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sakai, M., Kubota, T., Takaoka, M. et al. Successful re-administration of lenalidomide after lenalidomide-induced pulmonary alveolar hemorrhage in a patient with refractory myeloma. Ann Hematol 94, 891–892 (2015). https://doi.org/10.1007/s00277-014-2260-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-014-2260-4